Three More Drugs Have Been Added to the SGK Reimbursement List.
22 Articles
22 Articles
Minister of Labor and Social Security Vedat Işıkhan announced that two more Hemophilia B drugs and one cancer drug have been added to the Social Security Institution's (SGK) reimbursement list. The amount paid by SGK for magistral medicines produced in pharmacies has also been increased by 40 percent.
Cumhuriyet
Minister of Labor and Social Security Vedat Işıkhan announced that 2 Hemophilia B drugs and 1 cancer drug have been added to the Social Security Institution's reimbursement list.
Minister of Labor and Social Security Vedat Işıkhan announced that two more Hemophilia B drugs and one cancer drug have been added to the Social Security Institution's (SGK) reimbursement list. Minister Işıkhan shared this information on his NSosyal social media account, citing the 'Social Security Institution Health Application...' published in the Official Gazette.
Health Minister Kemal Memişoğlu announced that support for magistral medicines has been increased by 40 percent, two hemophilia B drugs and one cancer drug have been included in the reimbursement coverage, family physicians have been authorized to prescribe Leflunomide, and some procedures in pediatric surgery have been added to the reimbursement coverage.
Minister of Labor and Social Security Vedat Işıkhan announced that, with the regulation published in the Official Gazette, 3 drugs, one of which is domestically produced, have been added to the Social Security Institution's reimbursement list. With this regulation, payments for magistral medicines have been increased by 40 percent, and new steps have been taken in pediatric surgery and bone marrow transplantation processes.
Minister of Labor and Social Security Vedat Işıkhan announced that with the new regulations made in the Health Application Circular, 3 drugs, including 2 hemophilia B drugs and 1 cancer drug, one of which is domestically produced, have been included in the reimbursement coverage.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
